DEXCOM INC (1DXCM.MI) Stock Overview
Europe - BIT:1DXCM - US2521311074 - Common Stock
1DXCM.MI Key Statistics, Chart & Performance
The current stock price of 1DXCM.MI is 59.05 EUR.
1DXCM.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 24.97 | 186.44B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 63.2 | 167.66B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 54.14 | 143.61B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 34.25 | 128.91B | ||
| 1BSX.MI | BOSTON SCIENTIFIC CORP | 35.31 | 127.13B | ||
| 2M6.DE | MEDTRONIC PLC | 16.95 | 103.27B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 20.66 | 55.45B | ||
| BOX.DE | BECTON DICKINSON AND CO | 12.94 | 45.52B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 31.72 | 41.16B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 17.04 | 23.63B | ||
| DC4.DE | DEXCOM INC | 40.26 | 23.05B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.31 | 22.62B |
Related stock screener links
About 1DXCM.MI
Company Profile
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. The company is headquartered in San Diego, California and currently employs 10,300 full-time employees. The company went IPO on 2005-04-14. The firm is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The firm enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
Company Info
DEXCOM INC
6340 Sequence Drive
San Diego CALIFORNIA US
Employees: 10250
Phone: 18582000200
DEXCOM INC / 1DXCM.MI FAQ
Can you describe the business of DEXCOM INC?
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. The company is headquartered in San Diego, California and currently employs 10,300 full-time employees. The company went IPO on 2005-04-14. The firm is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The firm enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
What is the current price of 1DXCM stock?
The current stock price of 1DXCM.MI is 59.05 EUR. The price decreased by -2.78% in the last trading session.
Does 1DXCM stock pay dividends?
1DXCM.MI does not pay a dividend.
What is the ChartMill rating of DEXCOM INC stock?
1DXCM.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Would investing in DEXCOM INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1DXCM.MI.
1DXCM.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1DXCM.MI.
1DXCM.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1DXCM.MI. While 1DXCM.MI has a great profitability rating, there are some minor concerns on its financial health.
1DXCM.MI Financial Highlights
Over the last trailing twelve months 1DXCM.MI reported a non-GAAP Earnings per Share(EPS) of 1.46. The EPS decreased by -2.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.29% | ||
| ROA | 7.8% | ||
| ROE | 22.21% | ||
| Debt/Equity | 0.5 |
1DXCM.MI Forecast & Estimates
For the next year, analysts expect an EPS growth of 26.84% and a revenue growth 14.99% for 1DXCM.MI